Larvol Delta - cAMPfield-Launches-With-180-Million-Series-A-to-Advance-Prifemilast-a-Potential-BestinClass-Oral-Therapy-for-IBD

prifemilast (HPP737) - cAMPfield Therapeutics

https://www.prnewswire.com/news-releases/campfield-launches-with-180-million-series-a-to-advance-prifemilast-a-potential-best-in-class-oral-therapy-for-ibd-302803868.html

Jun 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next